Matthew Guo, MD (@matthewguomd) 's Twitter Profile
Matthew Guo, MD

@matthewguomd

PGY-1 @OslerResidency via @HopkinsMedicine @Cornell || Love to talk immuno-oncology, cancer survivorship, #MedEd, and my dog || Swammer now runner

ID: 2189380620

calendar_today12-11-2013 01:42:53

219 Tweet

594 Followers

585 Following

Ashish Vankara (@ashishvankara) 's Twitter Profile Photo

Grateful for holiday skiing with med school friends! Learning to ski later in life has reinforced the importance of lifelong learning. I'm lucky to have friends who support me, especially as I ‘yard sale’ on the slopes! Here’s to embracing new challenges! #LifelongLearning

Grateful for holiday skiing with med school friends! Learning to ski later in life has reinforced the importance of lifelong learning. I'm lucky to have friends who support me, especially as I ‘yard sale’ on the slopes! Here’s to embracing new challenges! #LifelongLearning
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Look at characteristics of immunotherapy response in NSCLC Clinical Lung Cancer. Compared 37 long-term responses (OS ≥ 3y w/ IO) & 35 without response (OS 6-12m w/ IO). Responders with more irAE & #KRAS. No difference in age, sex, race, BMI, liver mets, PDL1. clinical-lung-cancer.com/article/S1525-…

Matthew Guo, MD (@matthewguomd) 's Twitter Profile Photo

Our study from Johns Hopkins Thoracic Oncology Johns Hopkins Kimmel Cancer Center out now describing how unmet physical and/or social needs are associated with lower patient-reported quality of life and higher financial toxicity. Lots of work needed to provide more comprehensive survivorship care for our patients

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Outcomes with first-line osimertinib in 37 pts with rare atypical #EGFR exon 19 or compound mutations in #JTOCRR JTO & JTO CRR from Dr. Susan Combs Scott, MD Tia Cheunkarndee. RR 76%, median PFS 13m, time to discontinuation 22m, mOS 36m. jtocrr.org/article/S2666-…

Matthew Guo, MD (@matthewguomd) 's Twitter Profile Photo

Our pre-proof out now in JTO & JTO CRR showing favorable but heterogenous responses to 1L osimertinib for uncommon EGFR mutations in NSCLC. Congrats Tia Cheunkarndee for leading this effort identifying the need for more individualized care! #LCSM sciencedirect.com/science/articl…

Tia Cheunkarndee (@tiacheunkarndee) 's Twitter Profile Photo

So excited to share our work on 1L osimertinib for uncommon ex19del and compound EGFRm in NSCLC! Huge thanks to Susan Combs Scott, MD, Kristen A. Marrone, MD, @MatthewGuo316, Johns Hopkins Thoracic Oncology for their mentorship on this project :) sciencedirect.com/science/articl…

So excited to share our work on 1L osimertinib for uncommon ex19del and compound EGFRm in NSCLC! Huge thanks to <a href="/SusanScottMD/">Susan Combs Scott, MD</a>, <a href="/kamarroneMD/">Kristen A. Marrone, MD</a>, @MatthewGuo316, <a href="/HopkinsThoracic/">Johns Hopkins Thoracic Oncology</a> for their mentorship on this project :) sciencedirect.com/science/articl…
Matthew Guo, MD (@matthewguomd) 's Twitter Profile Photo

My dad died suddenly 4 years ago today. In med school I struggled with guilt, anger and grief as my CPR failed. I wasn’t sure I could or even wanted to graduate. Tomorrow is my first day of residency- I’m still not sure I can do it without him. Here’s to trying though, day by day

My dad died suddenly 4 years ago today. In med school I struggled with guilt, anger and grief as my CPR failed. I wasn’t sure I could or even wanted to graduate. Tomorrow is my first day of residency- I’m still not sure I can do it without him. Here’s to trying though, day by day
The Osler Medical Residency (@oslerresidency) 's Twitter Profile Photo

It’s almost July 1! Can’t wait to see this amazing new group of Osler interns grow and take fantastic care of patients under the leadership of their ACSs! #Oslerpride

It’s almost  July 1! Can’t wait to see this amazing new group of Osler interns grow and take fantastic care of patients under the leadership of their ACSs! #Oslerpride
The Osler Medical Residency (@oslerresidency) 's Twitter Profile Photo

Happy Friday from the Osler Medical Residency! Fantastic Thayer ACS rounds with⚓️ SAR @nathaliemorales and #FlagshipACS @MikeRoseMDMPH -discussions of meds increasing risk for UGIB, silhouette sign on CXR, unstable A fib management, and more #oslerpride #nicescarf #nicetie

Happy Friday from the Osler Medical Residency!  Fantastic Thayer ACS rounds with⚓️ SAR @nathaliemorales and #FlagshipACS @MikeRoseMDMPH -discussions of meds increasing risk for UGIB, silhouette sign on CXR, unstable A fib management, and more #oslerpride #nicescarf #nicetie
Ferdinandos Skoulidis (@fskoulidis) 's Twitter Profile Photo

Excited to share our new study nature. Very grateful for the support of our collaborators, pharma and biotech partners and members of the Skoulidis and Heymach labs. Special thanks to star fellow haniel.araujo and Minh Truong Do. Thankful to our patients. MD Anderson Cancer Center

Excited to share our new study <a href="/Nature/">nature</a>. Very grateful for the support of our collaborators, pharma and biotech partners and members of the Skoulidis and Heymach labs. Special thanks to star fellow <a href="/_hanielaraujo/">haniel.araujo</a> and <a href="/minhtruongdo/">Minh Truong Do</a>. Thankful to our patients. <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>
Matthew Guo, MD (@matthewguomd) 's Twitter Profile Photo

Ran my fourth half marathon yesterday! Still trying to decide which gives me more of an adrenaline rush- race day culture or getting pimped on The Osler Medical Residency ACS rounds post-call ☺️

Ran my fourth half marathon yesterday! Still trying to decide which gives me more of an adrenaline rush- race day culture or getting pimped on <a href="/OslerResidency/">The Osler Medical Residency</a> ACS rounds post-call ☺️